202 filings
Page 3 of 11
10-Q
2023 Q1
APGN
Apexigen Inc
Quarterly report
15 May 23
4:38pm
8-K
APGN
Apexigen Inc
12 Apr 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:25pm
424B3
APGN
Apexigen Inc
10 Apr 23
Prospectus supplement
4:03pm
424B3
APGN
Apexigen Inc
10 Apr 23
Prospectus supplement
4:02pm
EFFECT
APGN
Apexigen Inc
10 Apr 23
Notice of effectiveness
12:15am
EFFECT
APGN
Apexigen Inc
10 Apr 23
Notice of effectiveness
12:15am
POS AM
APGN
Apexigen Inc
4 Apr 23
Prospectus update (post-effective amendment)
4:24pm
POS AM
APGN
Apexigen Inc
4 Apr 23
Prospectus update (post-effective amendment)
4:23pm
EFFECT
APGN
Apexigen Inc
22 Mar 23
Notice of effectiveness
12:15am
424B3
APGN
Apexigen Inc
21 Mar 23
Prospectus supplement
4:33pm
CORRESP
APGN
Apexigen Inc
20 Mar 23
Correspondence with SEC
12:00am
S-1/A
APGN
Apexigen Inc
IPO registration (amended)
17 Mar 23
4:02pm
8-K
APGN
Apexigen Inc
27 Feb 23
Apexigen Announces Review of Strategic Alternatives and Restructuring
4:31pm
S-1
APGN
Apexigen Inc
IPO registration
22 Feb 23
4:21pm
10-K
2022 FY
APGN
Apexigen Inc
Annual report
22 Feb 23
4:08pm
8-K
APGN
Apexigen Inc
14 Feb 23
Departure of Directors or Certain Officers
6:25am
D
APGN
Apexigen Inc
13 Feb 23
$5.59 mm in equity / options / securities to be acquired, sold $5.59 mm, 13 investors
7:53pm
SC 13G/A
APGN
Apexigen Inc
13 Feb 23
Apexigen / PERISCOPE CAPITAL ownership change
4:10pm
SC 13G
Xiaodong Yang
13 Feb 23
Apexigen / Yang Xiaodong ownership change
4:04pm
8-K
APGN
Apexigen Inc
1 Feb 23
Unregistered Sales of Equity Securities
4:06pm